Quantisnow Logo
Dashboard

SEC Form SC 13G/A filed by Hanger Inc. (Amendment)

$HNGR
Medical Specialities
Health Care
Get the next $HNGR alert in real time by email
SC 13G/A 1 hngr13gadec21.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4) HANGER, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 41043F208 (CUSIP NUMBER) December 31, 2021 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 1,052,951 6. Shared Voting Power* 0 7. Sole Dispositive Power* 4,149,704 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,149,704 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 10.7% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. 1. Name of Reporting Person T. ROWE PRICE SMALL-CAP STOCK FUND, INC. 23-1622210 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 1,775,002 6. Shared Voting Power* 0 7. Sole Dispositive Power* 0 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,775,002 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 4.5% 12. Type of Reporting Person IV *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: HANGER, INC. Item 1(b) Address of Issuer's Principal Executive Offices: 10910 DOMAIN DRIVE, SUITE 300, AUSTIN, TEXAS 78758 Item 2(a) Name of Person(s) Filing: (1) T. ROWE PRICE ASSOCIATES, INC. ("Price Associates") (2) T. ROWE PRICE SMALL-CAP STOCK FUND, INC. X Attached as Exhibit A is a copy of an agreement between the Persons Filing (as specified hereinabove) that this Schedule 13G is being filed on behalf of each of them. Item 2(b) Address of Principal Business Office: 100 E. Pratt Street, Baltimore, MD 21202 Item 2(c) Citizenship or Place of Organization: (1) Maryland (2) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 41043F208 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 X Investment Company registered under Section 8 of the Investment Company Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class This statement is being filed to report the fact that, as of the date of this report, T. ROWE PRICE SMALL-CAP STOCK FUND, INC. has ceased to be the beneficial owner of more than five percent of the class of securities. This Item 5 is not applicable with respect to Price Associates. Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Associates does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Associates serves as investment adviser. Any and all discretionary authority which has been delegated to Price Associates may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Associates which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Associates. (2) With respect to securities owned by any one of the T. Rowe Price Funds, only the custodian for each of such Funds, has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. No other person is known to have such right, except that the shareholders of each such Fund participate proportionately in any dividends and distributions so paid. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. ROWE PRICE ASSOCIATES, INC. Date: February 14, 2022 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President T. ROWE PRICE SMALL-CAP STOCK FUND, INC. Date: February 14, 2022 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President 12/31/2021 EXHIBIT A AGREEMENT JOINT FILING OF SCHEDULE 13G Price Associates, Inc. (an investment adviser registered under the Investment Advisers Act of 1940), and T. ROWE PRICE SMALL-CAP STOCK FUND, INC., all of which are Maryland corporations, hereby agree to file jointly the statement on Schedule 13G to which this Agreement is attached, and any amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Securities Exchange Act of 1934. It is understood and agreed that each of the parties hereto is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, but such party is not responsible for the completeness or accuracy of information concerning the other party unless such party knows or has reason to believe that such information is inaccurate. It is understood and agreed that a copy of this Agreement shall be attached as an exhibit to the statement on Schedule 13G, and any amendments hereto, filed on behalf of each of the parties hereto. T. ROWE PRICE ASSOCIATES, INC. Date: February 14, 2022 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President T. ROWE PRICE SMALL-CAP STOCK FUND, INC. Date: February 14, 2022 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President
Get the next $HNGR alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$HNGR

DatePrice TargetRatingAnalyst
7/25/2022$24.00 → $18.75Buy → Hold
Jefferies
More analyst ratings

$HNGR
 Press Releases

Fastest customizable press release news feed in the world

See more

  • Hanger, Inc. Completes Acquisition by Patient Square Capital

    Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on July 21, 2022, and Hanger's stockholders approved the transaction at a Special Meeting of Stockholders held on September 30, 2022. As a result of the completion of the acquisition, Hanger stockholders will receive $18.75 in cash per share of common stock, and Hanger's common stock will no longer be traded on the New York Stock Exchange (NYSE). Wit

    $HNGR
    Medical Specialities
    Health Care

  • Hanger, Inc. Stockholders Approve Acquisition by Patient Square Capital

    Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced that its stockholders approved at a special meeting the acquisition of Hanger by Patient Square Capital, a leading dedicated health care investment firm. Vinit Asar, Hanger's President and Chief Executive Officer said, "I would like to express my gratitude to the Hanger stockholders for their support today, and throughout this transaction process. The Hanger team is excited about this partnership with Patient Square Capital, and beginning our next chapter as a private company. We believe this collaboration will enable us to accelerate our growth and enhance our

    $HNGR
    Medical Specialities
    Health Care

  • Frontier Communications Set to Join S&P MidCap 400; Hain Celestial Group to Join S&P SmallCap 600

    NEW YORK, Sept. 27, 2022 /PRNewswire/ -- Frontier Communications Parent Inc. (NASD: FYBR) will replace The Hain Celestial Group Inc. (NASD:HAIN) in the S&P Midcap 400 and The Hain Celestial Group will replace Hanger Inc. (NYSE:HNGR) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, October 3. Patient Square Capital, LP. is acquiring Hanger in a deal expected to be completed soon pending final closing conditions. The Hain Celestial Group is more representative of the small-cap market space. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Se

    $FYBR
    $HAIN
    $HNGR
    $SPGI
    Telecommunications Equipment
    Telecommunications
    Packaged Foods
    Consumer Staples

$HNGR
 Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$HNGR
 Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$HNGR
 SEC Filings

See more

$HNGR
 Leadership Updates

Live Leadership Updates

See more

  • Evolent Health Appoints Seth R. Frank as Vice President, Investor Relations

    WASHINGTON, Dec. 1, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Seth R. Frank has joined the company as Vice President, Investor Relations, effective immediately. Reporting to John Johnson, Evolent's Chief Financial Officer, Seth will lead Evolent's investor relations (IR) strategy and oversee its relationships with the investment community. "Seth provides a demonstrated track record of proactive, finance-driven leadership in health care investor relations to Evolent," said Evolent Health Chief Financial Officer John Johnson. "He brings long-ter

    $EVH
    $HNGR
    $MDRX
    Other Consumer Services
    Consumer Discretionary
    Medical Specialities
    Health Care

$HNGR
 Financials

Live finance-specific insights

See more

  • Hanger Reports Second Quarter 2022 Financial Results

    Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the second quarter and six months ended June 30, 2022. Financial Highlights Net revenues were $312.0 million for the three months ended June 30, 2022, compared to $280.8 million for the same period in 2021, reflecting growth of 11.1 percent. Patient Care same clinic revenue growth per day was 6.2 percent during the period. Net income was $10.1 million for the three months ended June 30, 2022, compared to $10.2 million for the same period in 2021. Income from operations was $20.8 million for the quarter compared to $20.1 million for

    $HNGR
    Medical Specialities
    Health Care

  • Hanger, Inc. Announces Definitive Agreement to be Acquired by Patient Square Capital for $18.75 Per Share in Cash

    Total Enterprise Value of Approximately $1.25 Billion Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today that it has entered into a definitive agreement to be acquired by Patient Square Capital, a dedicated health care investment firm. Under the terms of the agreement, which has been unanimously approved by Hanger's Board of Directors, Hanger stockholders will receive $18.75 in cash per share, representing an approximately 29% premium to the 30 calendar day volume-weighted average price (VWAP) ending July 20, 2022, and a total enterprise value of approximately $1.25 billion. Upon completion of the transaction,

    $HNGR
    Medical Specialities
    Health Care

  • Hanger Announces Date of 2022 Second Quarter Earnings Release and Conference Call

    Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced it will report its financial results for the second quarter and six months ended June 30, 2022 after the stock market closes on Monday, August 8, 2022. Hanger's management team will host a conference call to discuss the second quarter 2022 financial results the following morning on Tuesday, August 9, 2022 at 8:30 a.m. Eastern time. To participate in the Company's live conference call, please dial (844) 200-6205 or +1 (929) 526-1599 for international participants and reference access code 020458. A live webcast, replay of the call and earnings release, will be availa

    $HNGR
    Medical Specialities
    Health Care

$HNGR
 Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more